Results for tag: "Defitelio"

Defitelio is a brand of liver and kidney disorder drugs used to treat severe hepatic veno-occlusive disease (VOD) and acute kidney injury (AKI). Defitelio is a liposomal formulation of the active ingredient defibrotide, which is a single-stranded polydeoxyribonucleotide. Defitelio is used to treat VOD in patients who have undergone hematopoietic stem cell transplantation (HSCT). It is also used to treat AKI in patients who have undergone HSCT and are at risk of developing VOD. Defitelio is administered intravenously and is available in both single-use and multi-use vials. The Defitelio market is composed of a variety of companies that manufacture and distribute the drug. These companies include Jazz Pharmaceuticals, Inc., Novartis AG, and Gilead Sciences, Inc. Other companies involved in the Defitelio market include Merck & Co., Inc., Pfizer Inc., and Bristol-Myers Squibb Company. Show Less Read more